Evolus

EOLS · NASDAQ

$7.37+$0.01 (+0.14%)TodayMarket closed ·
Prev close $7.36

Who owns EOLS

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 52.1% of EOLS’s shares.

  • Lynch (Timothy Patrick)9.8%
  • Nantahala Capital Management, LLC8.5%
  • BlackRock Institutional Trust Company, N.A.6.5%
  • Soleus Capital Management, L.P.5.3%
  • Next 6 largest institutions22.1%
  • All other shareholders47.9%
Top institutional holders of EOLS
HolderShares% of shares
Lynch (Timothy Patrick)6.43M9.76%
Nantahala Capital Management, LLC5.60M8.51%
BlackRock Institutional Trust Company, N.A.4.28M6.50%
Soleus Capital Management, L.P.3.48M5.28%
Braidwell LP3.16M4.79%
Frazier Life Sciences Management, L.P.2.63M3.99%
Perceptive Advisors LLC2.46M3.73%
Vanguard Capital Management, LLC2.36M3.59%
Medy Tox Inc2.14M3.24%
Millennium Management LLC1.79M2.72%

Largest mutual fund holders

Top mutual fund holders of EOLS
HolderShares% of shares
Vanguard Total Stock Market Index Fund1.54M2.35%
iShares Russell 2000 ETF1.53M2.33%
Vanguard Extended Market Index Fund771.73K1.17%
Fidelity Small Cap Index Fund642.45K0.98%
iShares Russell 2000 Growth ETF561.93K0.85%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $950.02K (1 trade) of EOLS on the open market, with no buys.

Latest EOLS insider transactions
InsiderTypeSharesValue
MOATAZEDI DAVIDSale105.11K$950.02K

Short interest

Settled Sep 30, 2026

Shares short
5.63M
Days to cover
9.33
% of shares outstanding
8.55%
Average daily volume
603.49K
Change since last report
+1.8%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.